Cargando…

Bacteraemia and fungaemia in cystic fibrosis patients with febrile pulmonary exacerbation: a prospective observational study

BACKGROUND: Bloodstream pathogens can be identified by multiplex PCR (SeptiFast (SF)) or blood culture (BC); whether these pathogens are present in cystic fibrosis (CF) patients during febrile pulmonary exacerbations (FPE) has not been sufficiently studied. METHODS: In this prospective observational...

Descripción completa

Detalles Bibliográficos
Autores principales: Grosse-Onnebrink, Joerg, Stehling, Florian, Tschiedel, Eva, Olivier, Margarete, Mellies, Uwe, Schmidt, Rene, Buer, Jan, Rath, Peter-Micheal, Steinmann, Joerg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5492183/
https://www.ncbi.nlm.nih.gov/pubmed/28662657
http://dx.doi.org/10.1186/s12890-017-0440-4
_version_ 1783247275329323008
author Grosse-Onnebrink, Joerg
Stehling, Florian
Tschiedel, Eva
Olivier, Margarete
Mellies, Uwe
Schmidt, Rene
Buer, Jan
Rath, Peter-Micheal
Steinmann, Joerg
author_facet Grosse-Onnebrink, Joerg
Stehling, Florian
Tschiedel, Eva
Olivier, Margarete
Mellies, Uwe
Schmidt, Rene
Buer, Jan
Rath, Peter-Micheal
Steinmann, Joerg
author_sort Grosse-Onnebrink, Joerg
collection PubMed
description BACKGROUND: Bloodstream pathogens can be identified by multiplex PCR (SeptiFast (SF)) or blood culture (BC); whether these pathogens are present in cystic fibrosis (CF) patients during febrile pulmonary exacerbations (FPE) has not been sufficiently studied. METHODS: In this prospective observational study, blood from CF patients experiencing FPE was tested with SF and BC before the initiation of antibiotic treatment. RESULTS: After contaminants had been excluded, 9 of 72 blood samples tested positive by BC or SF. SF exclusively detected four pathogens; BC, one. Pulmonary pathogen transmission was likely in all cases except for 2 cases of candidaemia, which were believed to be caused by catheter-related infections. For three cases, test results caused us to change the antibiotic regimen. Sensitivity (85.7% vs. 42.9%) and negative predictive value (98.4% vs. 87.0%) tended to be higher for SF than for BC. CONCLUSIONS: The results of SF and BC show that bacteraemia and fungaemia are present in CF patients during FPE and may affect antibiotic therapy. SF can help rule out catheter-related bloodstream infections.
format Online
Article
Text
id pubmed-5492183
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-54921832017-06-30 Bacteraemia and fungaemia in cystic fibrosis patients with febrile pulmonary exacerbation: a prospective observational study Grosse-Onnebrink, Joerg Stehling, Florian Tschiedel, Eva Olivier, Margarete Mellies, Uwe Schmidt, Rene Buer, Jan Rath, Peter-Micheal Steinmann, Joerg BMC Pulm Med Research Article BACKGROUND: Bloodstream pathogens can be identified by multiplex PCR (SeptiFast (SF)) or blood culture (BC); whether these pathogens are present in cystic fibrosis (CF) patients during febrile pulmonary exacerbations (FPE) has not been sufficiently studied. METHODS: In this prospective observational study, blood from CF patients experiencing FPE was tested with SF and BC before the initiation of antibiotic treatment. RESULTS: After contaminants had been excluded, 9 of 72 blood samples tested positive by BC or SF. SF exclusively detected four pathogens; BC, one. Pulmonary pathogen transmission was likely in all cases except for 2 cases of candidaemia, which were believed to be caused by catheter-related infections. For three cases, test results caused us to change the antibiotic regimen. Sensitivity (85.7% vs. 42.9%) and negative predictive value (98.4% vs. 87.0%) tended to be higher for SF than for BC. CONCLUSIONS: The results of SF and BC show that bacteraemia and fungaemia are present in CF patients during FPE and may affect antibiotic therapy. SF can help rule out catheter-related bloodstream infections. BioMed Central 2017-06-29 /pmc/articles/PMC5492183/ /pubmed/28662657 http://dx.doi.org/10.1186/s12890-017-0440-4 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Grosse-Onnebrink, Joerg
Stehling, Florian
Tschiedel, Eva
Olivier, Margarete
Mellies, Uwe
Schmidt, Rene
Buer, Jan
Rath, Peter-Micheal
Steinmann, Joerg
Bacteraemia and fungaemia in cystic fibrosis patients with febrile pulmonary exacerbation: a prospective observational study
title Bacteraemia and fungaemia in cystic fibrosis patients with febrile pulmonary exacerbation: a prospective observational study
title_full Bacteraemia and fungaemia in cystic fibrosis patients with febrile pulmonary exacerbation: a prospective observational study
title_fullStr Bacteraemia and fungaemia in cystic fibrosis patients with febrile pulmonary exacerbation: a prospective observational study
title_full_unstemmed Bacteraemia and fungaemia in cystic fibrosis patients with febrile pulmonary exacerbation: a prospective observational study
title_short Bacteraemia and fungaemia in cystic fibrosis patients with febrile pulmonary exacerbation: a prospective observational study
title_sort bacteraemia and fungaemia in cystic fibrosis patients with febrile pulmonary exacerbation: a prospective observational study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5492183/
https://www.ncbi.nlm.nih.gov/pubmed/28662657
http://dx.doi.org/10.1186/s12890-017-0440-4
work_keys_str_mv AT grosseonnebrinkjoerg bacteraemiaandfungaemiaincysticfibrosispatientswithfebrilepulmonaryexacerbationaprospectiveobservationalstudy
AT stehlingflorian bacteraemiaandfungaemiaincysticfibrosispatientswithfebrilepulmonaryexacerbationaprospectiveobservationalstudy
AT tschiedeleva bacteraemiaandfungaemiaincysticfibrosispatientswithfebrilepulmonaryexacerbationaprospectiveobservationalstudy
AT oliviermargarete bacteraemiaandfungaemiaincysticfibrosispatientswithfebrilepulmonaryexacerbationaprospectiveobservationalstudy
AT melliesuwe bacteraemiaandfungaemiaincysticfibrosispatientswithfebrilepulmonaryexacerbationaprospectiveobservationalstudy
AT schmidtrene bacteraemiaandfungaemiaincysticfibrosispatientswithfebrilepulmonaryexacerbationaprospectiveobservationalstudy
AT buerjan bacteraemiaandfungaemiaincysticfibrosispatientswithfebrilepulmonaryexacerbationaprospectiveobservationalstudy
AT rathpetermicheal bacteraemiaandfungaemiaincysticfibrosispatientswithfebrilepulmonaryexacerbationaprospectiveobservationalstudy
AT steinmannjoerg bacteraemiaandfungaemiaincysticfibrosispatientswithfebrilepulmonaryexacerbationaprospectiveobservationalstudy